netFormulary
 Report : A-Z NHS England items in Formulary 12/04/2021 01:51:24
[Back]
 
Section Status NHS England Name
05.03.01 Formulary MHS England Abacavir and Lamivudine generic brands
11.04.02 Restricted Use MHS England Adalimumab Humira
13.05.03 Formulary MHS England Adalimumab Humira
08.01.05 Formulary MHS England Afatinib Giotrif
08.01.05 Formulary MHS England Alectinib Alecensa
08.02.04 Formulary MHS England Alemtuzumab Lemtrada
05.02.03 Restricted Use MHS England Amphotericin  Fungizone
05.02.03 Formulary MHS England Amphotericin Liposomal AmBisome
10.01.03 Restricted Use MHS England Anakinra Kineret
05.02.04 Formulary MHS England Anidulafungin Ecalta
08.02.02 Formulary MHS England Antithymocyte immunoglobulin (rabbit)  Thymoglobuline
08.01.05 Formulary MHS England Arsenic Trioxide Trisenox
08.01.05 Formulary MHS England Atezolizumab Tecentriq
08.01.05 Formulary MHS England Avelumab Bavencio
08.01.05 Formulary MHS England Axitinib Inlyta
05.01.02.03 Formulary MHS England Aztreonam Lysine nebuliser solution Cayston
08.02.02 Formulary MHS England Basiliximab Simulect
08.01.01 Formulary MHS England Bendamustine Levact
03.04.02 Restricted Use MHS England Benralizumab Fasenra
08.02.03 Formulary MHS England Blinatumomab Blincyto
08.01.05 Formulary MHS England Bortezomib Velcade
08.01.05 Formulary MHS England Bosutinib Bosulif
08.01.05 Formulary MHS England Brentuximab vedotin Adcetris
08.01.05 Formulary MHS England Brigatinib Alunbrig
08.01.05 Non Formulary MHS England Cabozantinib Cometriq
08.01.05 Formulary MHS England Cabozantinib Cometriq, Cabometyx
04.08.01 Restricted Use MHS England Cannabidiol Epidyolex
08.01.05 Formulary MHS England Carfilzomib Kyprolis
05.02.04 Formulary MHS England Caspofungin Generic, Cancidas
08.01.05 Formulary MHS England Ceritinib Zykadia
08.01.05 Formulary MHS England Cetuximab Erbitux
05.03.02.02 Formulary MHS England Cidofovir Vistide
08.02.04 Formulary MHS England Cladribine Mavenclad
05.01.07 Formulary MHS England Colistimethate for nebulisation Colomycin, Colistin, Promixin
05.01.07 Formulary MHS England Colistimethate inhaler Colobreathe
08.01.05 Formulary MHS England Crizotinib Xalkori
08.01.05 Formulary MHS England Dabrafenib Tafinlar
05.03.03.02 Formulary MHS England Daclatasvir Daklinza
08.02.04 Non Formulary MHS England Daclizumab Zinbryta
08.01.05 Formulary MHS England Dacomitinib Vizimpro
08.03.04.02 Formulary MHS England Darolutamide Nubeqa
05.03.01 Formulary MHS England Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg Symtuza
01.05.03 Non Formulary MHS England Darvadstrocel Alofisel
05.03.03.02 Formulary MHS England Dasabuvir Exviera
08.02.04 Formulary MHS England Dimethyl fumarate Tecfidera
08.01.05 Restricted Use MHS England Dinumtuximab Qarziba
03.07 Formulary MHS England Dornase Alfa Pulmozyme
13.05.03 Formulary MHS England Dupilumab Dupixent
05.03.03.02 Formulary MHS England Elbasvir with Grazoprevir Zepatier
09.08.01 Restricted Use MHS England Eliglustat Cerdelga®
02.11 Restricted Use MHS England Emicizumab Hemlibra
05.03.01 Formulary MHS England Emtricitabine and tenofovir Generic, Truvada
05.03.01 Formulary MHS England Emtricitabine, efavirenz and tenofovir  Generic, Atripla
08.01.05 Formulary MHS England Encorafenib Braftovi
05.03.03.01 Formulary MHS England Entecavir Generic, Baraclude
08.01.05 Formulary MHS England Entrectinib Rozlytrek
08.03.04.02 Non Formulary MHS England Enzalutamide Xtandi
09.05.01.02 Formulary MHS England Etelcalcetide Parsabiv
08.02.04 Formulary MHS England Fingolimod Gilenya
05.03.02.02 Formulary MHS England Foscarnet Sodium Foscavir
05.03.02.02 Formulary MHS England Ganciclovir Cymevene
08.01.05 Formulary MHS England Gemtuzumab ozogamicin MYLOTARG
08.01.05 Formulary MHS England Gilteritinib Xospata
08.02.04 Formulary MHS England Glatiramer Acetate Copaxone
05.03.03.02 Formulary MHS England Glecaprevir with Pibrentasvir Maviret
11.99.99.99 Restricted Use MHS England Holoclar Viable autologous human corneal epithelial cells
14.05.01 Formulary MHS England Human normal immunoglobulin  
08.01.05 Formulary MHS England Ibrutinib Imbruvica
08.01.05 Non Formulary MHS England Idelalisib Zydelig
08.01.05 Formulary MHS England Idelalisib Zydelig
08.01.05 Formulary MHS England Imatinib Generic, Glivec
09.08.01 Restricted Use MHS England Imiglucerase Cerezyme
08.01.05 Formulary MHS England Inotuzumab ozogamicin BESPONSA
08.02.04 Formulary MHS England Interferon Beta-1a & Interferon Beta 1-b Avonex, Rebif, Extavia
08.01.05 Formulary MHS England Ipilimumab YERVOY
05.02.01 Restricted Use MHS England Isavuconazole CRESEMBA
03.12 Formulary MHS England Ivacaftor 150mg tablets Kalydeco
03.12 Formulary MHS England Ivacaftor/Tezacaftor/Elexacaftor Kaftrio
05.03.03.01 Formulary MHS England Lamivudine Generic, Zeffix
03.04.03 Restricted Use MHS England Lanadelumab Takhzyro
08.03.04.03 Formulary MHS England Lanreotide Somatuline Autogel, Somatuline LA
09.05.02.02 Formulary MHS England Lanthanum Fosrenol
08.02.04 Formulary MHS England Lenalidomide Revlimid
08.02.04 Non Formulary MHS England Lenalidomide Revlimid
08.01.05 Formulary MHS England Lenvatinib Kisplyx, Lenvima
05.03.02.02 Restricted Use MHS England Letermovir Prevymis
08.01.05 Formulary MHS England Liposomal Cytarabine-Daunorubicin Vyxeos
08.01.05 Restricted Use MHS England Lorlatinib Lorviqua
03.12 Formulary MHS England lumacaftor/ivacaftor Orkambi
03.07 Formulary MHS England Mannitol  Bronchitol
03.04.02 Restricted Use MHS England Mepolizumab Nucala
04.09.03 Restricted Use MHS England Mexiletine NaMuscla
05.02.04 Formulary MHS England Micafungin Mycamine
08.01.05 Formulary MHS England Midostaurin Rydapt
08.02.04 Formulary MHS England Natalizumab Tysabri
08.01.05 Formulary MHS England Neratinib Nerlynx
03.11 Formulary MHS England Nintedanib Ofev
08.01.05 Formulary MHS England Nintedanib  Vargatef, Ofev
08.01.05 Formulary MHS England Nivolumab Opdivo
04.09.03 Restricted Use MHS England Nusinersen Spinraza
01.09.01 Restricted Use MHS England Obeticholic acid Ocaliva
08.02.03 Formulary MHS England Obinutuzumab  Gazyvaro
08.02.04 Formulary MHS England Ocrelizumab OCREVUS
08.03.04.03 Formulary MHS England Octreotide Sandostatin LAR
08.01.05 Formulary MHS England Olaparib Lynparza
03.04.02 Formulary MHS England Omalizumab Xolair
05.03.03.02 Formulary MHS England Ombitasvir with Paritaprevir and Ritonavir Viekirax
08.01.05 Formulary MHS England Osimertinib Tagrisso
08.01.05 Formulary MHS England Paclitaxel - Albumin Bound Formulation (Nab-paclitaxel) Abraxane
08.01.05 Formulary MHS England Palbociclib IBRANCE
08.01.05 Formulary MHS England Panitumumab Vectibix
08.02.04 Formulary MHS England Peginterferon beta-1a Plegridy
06.05.01 Restricted Use MHS England Pegvisomant Somavert
08.01.05 Formulary MHS England Pembrolizumab Keytruda
08.01.05 Formulary MHS England Pertuzumab Perjeta
03.11 Restricted Use MHS England Pirfenidone Esbriet
08.01.05 Formulary MHS England Polatuzumab vedotin Polivy
08.02.04 Non Formulary MHS England Pomalidomide Imnovid
08.02.04 Formulary MHS England Pomalidomide Imnovid
08.01.05 Formulary MHS England Ponatinib Iclusig
05.02.01 Formulary MHS England Posaconazole Noxafil
08.01.03 Formulary MHS England Raltitrexed Tomudex
08.01.05 Formulary MHS England Regorafenib Stivarga
03.04.02 Restricted Use MHS England Reslizumab Cinqaero
05.03.03.02 Formulary MHS England Ribavirin 
08.01.05 Formulary MHS England Ribociclib Kisqali
08.01.05 Formulary MHS England Ruxolitinib Jakavi
09.05.02.02 Formulary MHS England Sevelamer Carbonate Generic, Renvela
09.05.02.02 Formulary MHS England Sevelamer Hydrochloride  Renagel
08.02.04 Formulary MHS England Siponimod Mayzent®
08.02.02 Formulary MHS England Sirolimus Rapamune
04.01.01 Restricted Use MHS England Sodium Oxybate Xyrem
05.03.03.02 Formulary MHS England Sofosbuvir Sovaldi
05.03.03.02 Formulary MHS England Sofosbuvir with ledipasvir Harvoni
05.03.03.02 Formulary MHS England Sofosbuvir with velpatasvir Epclusa
05.03.03.02 Formulary MHS England Sofosbuvir with Velpatasvir and Voxilaprevir Vosevi
08.01.05 Formulary MHS England Sorafenib Nexavar
05.03.03.01 Formulary MHS England Tenofovir Disproxil Generic, Viread
08.02.04 Formulary MHS England Teriflunomide Aubagio
03.12 Formulary MHS England tezacaftor 100mg/ivacaftor 150mg Symkevi
08.02.04 Formulary MHS England Thalidomide Thalidomide Celgene
08.01.05 Formulary MHS England Tivozanib Fotivda
05.01.04 Formulary MHS England Tobramycin inhaler TOBI Podhaler
05.01.04 Formulary MHS England Tobramycin nebuliser solution 
06.05.02 Restricted Use MHS England Tolvaptan Samsca
08.01.05 Formulary MHS England Trametinib Mekinist
08.01.05 Formulary MHS England Trastuzumab Ontruzant, Herceptin
08.01.05 Formulary MHS England Trastuzumab emtansine Kadcyla
08.01.01 Formulary MHS England Treosulfan Trecondil
05.03.02.02 Formulary MHS England Valganciclovir Valcyte, Generic
09.08.01 Restricted Use MHS England Velaglucerase alfa VPRIV
08.01.05 Formulary MHS England Venetoclax Venclyxto
02.12 Formulary MHS England Volanesorsen Waylivra
02.11 Formulary MHS England Vonicog alfa Veyvondi®
11.99.99.99 Non Formulary MHS England Voretigene neparvovec Luxturna
05.02.01 Formulary MHS England Voriconazole Generic, VFEND
Dorset